Olga Černá

551 citations
22 papers · 416 · 1 hit paper · h-index 8

Impact in

  • Genetics top 5%
    • Myeloproliferative Neoplasms: Diagnosis and Treatment
    • Chronic Myeloid Leukemia Treatments
    • Acute Myeloid Leukemia Research
    • Platelet Disorders and Treatments

Papers in

    • Chronic Myeloid Leukemia Treatments 4
    • Acute Myeloid Leukemia Research 4
    • Platelet Disorders and Treatments 2
    • Myeloproliferative Neoplasms: Diagnosis and Treatment 6
    • Genomic variations and chromosomal abnormalities 1

Olga Černá

21 papers receiving 405 citations

Olga Černá's Hit Papers

Ropeginterferon alfa-2b versus standard therapy for polycythaemia vera (PROUD-PV and CONTINUATION-PV): a randomised, non-inferiority, phase 3 trial and its extension study 2020 · 278 citations
2780+2+4Years since publication50100150200250

Peers

Olga Černá
Comparison fields: 5 of 38
  • Genetics 284
  • Hematology 59
  • Toxicology 12
  • Analytical Chemistry 10
  • Hepatology 7
Replace Kaitlin Kennard with:
Kaitlin Kennard United States
Spencer Henick Bachow United States
Shahla Ansari Iran
Michael Hadjigavriel Cyprus
A. Copplestone United Kingdom
S Terzoli Italy
Arvind K. Arumainathan United Kingdom
Michele Rizzo Italy
Giancarla Gerli Italy
H. A. Mylius Germany
Olga Černá relative to Kaitlin Kennard United States Kaitlin Kennard's profile →
Citations per field
00.5×2×4×5.9×
Kaitlin Kennard · 1×
Citations per year

Countries citing papers authored by Olga Černá

Since Specialization
Citations

This map shows the geographic impact of Olga Černá's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Olga Černá with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Olga Černá more than expected).

Fields of papers citing papers by Olga Černá

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Olga Černá. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Olga Černá. The network helps show where Olga Černá may publish in the future.

Co-authors

The 25 scholars most cited alongside Olga Černá, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Olga Černá Line = papers co-authored together Olga Černá links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 22 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Ropeginterferon alfa-2b versus standard therapy for polycythaemia vera (PROUD-PV and CONTINUATION-PV): a randomised, non-inferiority, phase 3 trial and its extension study
Hit paper breakdown →
2020278
2 201523
3 200921
4 201619
5 197612
6 202411
7 201210
8 20128
9 20126
10 20196
11 20195
12 20203
13
[Essential thrombocytemia and other myeloproliferations with thrombocytemia in the data of the register of patients treated with Thromboreductin till the end of 2006].
20072
14 20112
15
[Summary of recommendations for the diagnosis and therapy of BCR/ABL-negative myeloproliferation of the Czech Working Group for Ph-negative myeloproliferative disease (CZEMP) of the Czech Hematologic Society CLS JEP ].
20122
16 20242
17 20242
18
[Congenital fatal toxoplasmosis sepsis].
19871
19 20081
20 20121

About Olga Černá

Olga Černá is a scholar working on Hematology, Genetics, Pharmacology, Parasitology and Nutrition and Dietetics, having authored 22 papers that have together received 416 indexed citations. Recurring topics across this work include Myeloproliferative Neoplasms: Diagnosis and Treatment (6 papers), Chronic Myeloid Leukemia Treatments (4 papers), Acute Myeloid Leukemia Research (4 papers), Platelet Disorders and Treatments (2 papers), Antibiotics Pharmacokinetics and Efficacy (2 papers), Vitamin C and Antioxidants Research (1 paper), Genomic variations and chromosomal abnormalities (1 paper) and Toxoplasma gondii Research Studies (1 paper). The work is most often cited by research in Genetics (284 citations), Hematology (59 citations), Toxicology (12 citations), Analytical Chemistry (10 citations) and Hepatology (7 citations). Olga Černá has collaborated with scholars based in Czechia, Netherlands and Bulgaria. Frequent co-authors include Pavla Pokorná, Ondřej Slanař, Michael Doubek, František Perlík, Edgar Faber, Jaroslav Čermák, EMIL GINTER, Petra Ovesná, Martin Šíma and Petr Ďulíček. Their work appears in journals such as Blood, Leukemia Research, American Journal of Hematology, Scandinavian Journal of Infectious Diseases and European Journal Of Haematology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact